Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Assessment of Physical Activity Among Juvenile Idiopathic Arthritis Children Performed With Actigraphy (AJIACT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04167488
Recruitment Status : Recruiting
First Posted : November 19, 2019
Last Update Posted : November 19, 2019
Sponsor:
Information provided by (Responsible Party):
Centre Hospitalier Universitaire de Besancon

Brief Summary:
This study aims to describe physical activity among juvenile idiopathic arthritis children, according to the disease's and patient's characteristics.

Condition or disease Intervention/treatment Phase
Juvenile Idiopathic Arthritis Device: Actigraphic measurement Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 50 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Other
Official Title: Assessment of Physical Activity Among Juvenile Idiopathic Arthritis Children Performed With Actigraphy
Actual Study Start Date : September 10, 2019
Estimated Primary Completion Date : December 2019
Estimated Study Completion Date : December 2019


Arm Intervention/treatment
Experimental: Actigraphic measurement Device: Actigraphic measurement
Physical activity assessed with actigraphic device worn during 7 days




Primary Outcome Measures :
  1. Physical activity assessment [ Time Frame: Day 7 ]

    Physical activity will be measured with actigraphic device and children will be divided into 3 groups of activity levels: low / moderate / high.

    Low is < or = 1000 counts per minute Moderate is > 1000 counts per minute High is > 2500 per minute




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   4 Years to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Juvenile idiopathic arthritis evolving for more than a year

Exclusion Criteria:

  • intra-articular infiltration performed less than a month ago

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04167488


Contacts
Layout table for location contacts
Contact: Laure JONYK, Int 0033381218135 laure.jonyk@orange.fr

Locations
Layout table for location information
France
CHU de Besançon Recruiting
Besançon, France, 25000
Contact: Laure Jonyk, Int       laure.jonyk@orange.fr   
Principal Investigator: Claire BALLOT SCHMIT, MD         
Sponsors and Collaborators
Centre Hospitalier Universitaire de Besancon
Investigators
Layout table for investigator information
Principal Investigator: Claire BALLOT SCHMIT, MD CHU de Besançon

Layout table for additonal information
Responsible Party: Centre Hospitalier Universitaire de Besancon
ClinicalTrials.gov Identifier: NCT04167488    
Other Study ID Numbers: P/2019/432
First Posted: November 19, 2019    Key Record Dates
Last Update Posted: November 19, 2019
Last Verified: November 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Arthritis
Arthritis, Juvenile
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Connective Tissue Diseases
Autoimmune Diseases
Immune System Diseases